Mycobacterial Phenolic Glycolipid Triggers ATP-Mediated Neuronal P2X3 Signaling and Cough
Naqvi, K. F.; Warden, L. L.; van Dijk, J. H. M.; Naik, D. K.; Espinosa-Becarra, F. d. J.; Okolie, I. M.; Verhoeks, V. F. H.; Rahlwes, K. C.; Xavier, C. P.; Codee, J. D. C.; Price, T. J.; Shiloh, M. U.
Show abstract
Cough drives respiratory pathogen transmission, yet how microbes directly engage host sensory neurons to trigger cough is largely unknown. We previously demonstrated that the Mycobacterium tuberculosis (Mtb) glycolipid sulfolipid-1 (SL-1) activates neurons and induces cough. Here, we reveal that phenolic glycolipid (PGL) produced by the hypertransmissible HN878 Mtb strain activates both mouse and human nociceptive neurons in vitro using calcium imaging and electrophysiology and is sufficient to induce cough using plethysmography. Combined with SL-1, PGL potently triggers neuronal activation. By synthesizing various PGL analogs, we show that neuroactivity is proportional to saccharide chain length and structure. Mechanistically, PGL stimulates rapid extracellular ATP release, which engages neuronal P2X3 purinergic receptors--an effect blocked by a P2X3 antagonist. These findings uncover a neuronal activation pathway co-opted by certain Mtb strains to enhance transmission via cough and suggest inhibition of purinergic signaling as a potential strategy to block airborne spread of Mtb.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Antibiotic-induced accumulation of lipid II sensitizes bacteria to antimicrobial fatty acids 95%
- Computational design of peptides to target Nav1.7 channel with high potency and selectivity for the treatment of pain 95%
- Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain 95%
Similar papers in this journal
- Small-molecule inhibition of Lats kinases promotes Yap-dependent proliferation in postmitotic mammalian tissues 95%
- Coordination chemogenetics for activation of GPCR-type glutamate receptors in brain tissue 95%
- Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides 95%
Similar papers in this journal
Similar papers in this journal
- Discovery of an AIM2 inflammasome inhibitor for the treatment of DNA-driven inflammatory disease. 94%
- Brazilin is a Natural Product Inhibitor of the NLRP3 Inflammasome 94%
- A screening pipeline identifies a broad-spectrum inhibitor of bacterial AB toxins with cross protection against influenza A virus H1N1 and SARS-CoV-2 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.